Functional studies on circulating and disseminated tumor cells in carcinoma patients

Molecular Oncology

Volumn 10, Issue 3, 2016, Pages 443-449

  Alix Panabières, Catherine ^a,b   Bartkowiak, Kai ^c   Pantel, Klaus ^c  

^a University Medical Centre   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Biomarkers; Cell lines; CTCs; DTCs; Liquid biopsy; Solid tumors

Indexed keywords

BLOOD; BONE MARROW; BREAST CANCER; CANCER PATIENT; CIRCULATING TUMOR CELL; COLON CANCER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TUMOR XENOGRAFT; ANIMAL; BIOPSY; METABOLISM; NEOPLASM METASTASIS; NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; TUMOR EMBOLISM;

TUMOR MARKER;

ANIMALS; BIOMARKERS, TUMOR; BIOPSY; BONE MARROW; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS;

EID: 84959093230     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2016.01.004     Document Type: Review

References (41)

1. Alix-Panabieres C., Pantel K. Challenges in circulating tumour cell research. Nat. Rev. Cancer 2014, 14:623-631.
2. Alix-Panabieres C., Rebillard X., Brouillet J.P., Barbotte E., Iborra F., Segui B., Maudelonde T., Jolivet-Reynaud C., Vendrell J.P. Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients. Clin. Chem. 2005, 51:1538-1541.
3. Alix-Panabieres C., Vendrell J.P., Pelle O., Rebillard X., Riethdorf S., Muller V., Fabbro M., Pantel K. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin. Chem. 2007, 53:537-539.
4. Alix-Panabieres C., Vendrell J.P., Slijper M., Pelle O., Barbotte E., Mercier G., Jacot W., Fabbro M., Pantel K. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res. 2009, 11:R39.
5. Baccelli I., Schneeweiss A., Riethdorf S., Stenzinger A., Schillert A., Vogel V., Klein C., Saini M., Bauerle T., Wallwiener M., Holland-Letz T., Hofner T., Sprick M., Scharpff M., Marme F., Sinn H.P., Pantel K., Weichert W., Trumpp A. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat. Biotechnol. 2013, 31:539-544.
6. Balz L.M., Bartkowiak K., Andreas A., Pantel K., Niggemann B., Zanker K.S., Brandt B.H., Dittmar T. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-gamma1 signalling in breast cancer cell migration and dissemination. J. Pathol. 2012, 227:234-244.
7. Bartkowiak K., Kwiatkowski M., Buck F., Gorges T.M., Nilse L., Assman V., Andreas A., Müller V., Wikman H., Riethdorf S., Schlüter H., Pantel K. Disseminated tumor cells persist in the bone marrow of breast cancer patients through sustained activation of the unfolded protein response. Cancer Res. 2015, 75:5367-5377.
8. Bartkowiak K., Effenberger K.E., Harder S., Andreas A., Buck F., Peter-Katalinic J., Pantel K., Brandt B.H. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients. J. Proteome Res. 2010, 9:3158-3168.
9. Bartkowiak K., Wieczorek M., Buck F., Harder S., Moldenhauer J., Effenberger K.E., Pantel K., Peter-Katalinic J., Brandt B.H. Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem/progenitor cell protein profile. J. Proteome Res. 2009, 8:2004-2014.
10. Bidard F.C., Peeters D.J., Fehm T., Nole F., Gisbert-Criado R., Mavroudis D., Grisanti S., Generali D., Garcia-Saenz J.A., Stebbing J., Caldas C., Gazzaniga P., Manso L., Zamarchi R., de Lascoiti A.F., De Mattos-Arruda L., Ignatiadis M., Lebofsky R., van Laere S.J., Meier-Stiegen F., Sandri M.T., Vidal-Martinez J., Politaki E., Consoli F., Bottini A., Diaz-Rubio E., Krell J., Dawson S.J., Raimondi C., Rutten A., Janni W., Munzone E., Caranana V., Agelaki S., Almici C., Dirix L., Solomayer E.F., Zorzino L., Johannes H., Reis-Filho J.S., Pantel K., Pierga J.Y., Michiels S. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol. 2014, 15:406-414.
11. Bobek V., Gurlich R., Eliasova P., Kolostova K. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation. World J. Gastroenterol. 2014, 20:17163-17170.
12. Bobek V., Matkowski R., Gurlich R., Grabowski K., Szelachowska J., Lischke R., Schutzner J., Harustiak T., Pazdro A., Rzechonek A., Kolostova K. Cultivation of circulating tumor cells in esophageal cancer. Folia histochem. et cytobiol./Pol. Acad. Sci. Pol. Histochem. Cytochem. Soc. 2014, 52:171-177.
13. Cayrefourcq L., Mazard T., Joosse S., Solassol J., Ramos J., Assenat E., Schumacher U., Costes V., Maudelonde T., Pantel K., Alix-Panabieres C. Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res. 2015, 75:892-901.
14. David R. PD-L1 expression by circulating breast cancer cells. Lancet Oncol. 2015, 16:e321.
15. Deneve E., Riethdorf S., Ramos J., Nocca D., Coffy A., Daures J.P., Maudelonde T., Fabre J.M., Pantel K., Alix-Panabieres C. Capture of viable circulating tumor cells in the liver of colorectal cancer patients. Clin. Chem. 2013, 59:1384-1392.
16. Gao D., Vela I., Sboner A., Iaquinta P.J., Karthaus W.R., Gopalan A., Dowling C., Wanjala J.N., Undvall E.A., Arora V.K., Wongvipat J., Kossai M., Ramazanoglu S., Barboza L.P., Di W., Cao Z., Zhang Q.F., Sirota I., Ran L., MacDonald T.Y., Beltran H., Mosquera J.M., Touijer K.A., Scardino P.T., Laudone V.P., Curtis K.R., Rathkopf D.E., Morris M.J., Danila D.C., Slovin S.F., Solomon S.B., Eastham J.A., Chi P., Carver B., Rubin M.A., Scher H.I., Clevers H., Sawyers C.L., Chen Y. Organoid cultures derived from patients with advanced prostate cancer. Cell 2014, 159:176-187.
17. Goldkorn A., Ely B., Quinn D.I., Tangen C.M., Fink L.M., Xu T., Twardowski P., Van Veldhuizen P.J., Agarwal N., Carducci M.A., Monk J.P., Datar R.H., Garzotto M., Mack P.C., Lara P., Higano C.S., Hussain M., Thompson I.M., Cote R.J., Vogelzang N.J. Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. J. Clin. Oncol. 2014, 32:1136-1142.
18. Grabinski N., Bartkowiak K., Grupp K., Brandt B., Pantel K., Jucker M. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells. Cell Signal 2011, 1952-1960.
19. Hodgkinson C.L., Morrow C.J., Li Y., Metcalf R.L., Rothwell D.G., Trapani F., Polanski R., Burt D.J., Simpson K.L., Morris K., Pepper S.D., Nonaka D., Greystoke A., Kelly P., Bola B., Krebs M.G., Antonello J., Ayub M., Faulkner S., Priest L., Carter L., Tate C., Miller C.J., Blackhall F., Brady G., Dive C. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat. Med. 2014, 20:897-903.
20. Hou J.M., Krebs M.G., Lancashire L., Sloane R., Backen A., Swain R.K., Priest L.J., Greystoke A., Zhou C., Morris K., Ward T., Blackhall F.H., Dive C. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J. Clin. Oncol. 2012, 30:525-532.
21. Kang Y., Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell 2013, 23:573-581.
22. Kolostova K., Broul M., Schraml J., Cegan M., Matkowski R., Fiutowski M., Bobek V. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score. Anticancer Res. 2014, 34:3641-3646.
23. Kolostova K., Matkowski R., Gurlich R., Grabowski K., Soter K., Lischke R., Schutzner J., Bobek V. Detection and cultivation of circulating tumor cells in gastric cancer. Cytotechnology 2015.
24. Kolostova K., Spicka J., Matkowski R., Bobek V. Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers. Am. J. Translat. Res. 2015, 7:1203-1213.
25. Maheswaran S., Haber D.A. Ex vivo culture of CTCs: an emerging resource to guide cancer therapy. Cancer Res. 2015, 75:2411-2415.
26. Mazel M., Jacot W., Pantel K., Bartkowiak K., Topart D., Cayrefourcq L., Rossille D., Maudelonde T., Fest T., Alix-Panabieres C. Frequent expression of PD-L1 on circulating breast cancer cells. Mol. Oncol. 2015, 9:1773-1782.
27. Pantel K., Alix-Panabières C. Cell lines from circulating tumor cells. Oncoscience 2015, 2:815-816.
28. Pantel K., Dickmanns A., Zippelius A., Klein C., Shi J., Hoechtlen-Vollmar W., Schlimok G., Weckermann D., Oberneder R., Fanning E. Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J. Natl. Cancer Inst. 1995, 87:1162-1168.
29. Putz E., Witter K., Offner S., Stosiek P., Zippelius A., Johnson J., Zahn R., Riethmuller G., Pantel K. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res. 1999, 59:241-248.
30. Ramirez J.M., Fehm T., Orsini M., Cayrefourcq L., Maudelonde T., Pantel K., Alix-Panabieres C. Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients. Clin. Chem. 2014, 60:214-221.
31. Rossi E., Rugge M., Facchinetti A., Pizzi M., Nardo G., Barbieri V., Manicone M., De Faveri S., Chiara Scaini M., Basso U., Amadori A., Zamarchi R. Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients. Oncoscience 2014, 1:49-56.
32. Scher H.I., Heller G., Molina A., Attard G., Danila D.C., Jia X., Peng W., Sandhu S.K., Olmos D., Riisnaes R., McCormack R., Burzykowski T., Kheoh T., Fleisher M., Buyse M., de Bono J.S. Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer. J. Clin. Oncol. 2015, 33:1348-1355.
33. Solakoglu O., Maierhofer C., Lahr G., Breit E., Scheunemann P., Heumos I., Pichlmeier U., Schlimok G., Oberneder R., Kollermann M.W., Kollermann J., Speicher M.R., Pantel K. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proc. Natl. Acad. Sci. U S A 2002, 99:2246-2251.
34. Tam W.L., Weinberg R.A. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat. Med. 2013, 19:1438-1449.
35. Ueo H., Sugimachi K., Gorges T.M., Bartkowiak K., Yokobori T., Muller V., Shinden Y., Ueda M., Mori M., Kuwano H., Maehara Y., Ohno S., Pantel K., Mimori K. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer. Br. J. Cancer 2015, 112:1519-1526.
36. Willipinski-Stapelfeldt B., Riethdorf S., Assmann V., Woelfle U., Rau T., Sauter G., Heukeshoven J., Pantel K. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin. Cancer Res. 2005, 11:8006-8014.
37. Woelfle U., Cloos J., Sauter G., Riethdorf L., Janicke F., van Diest P., Brakenhoff R., Pantel K. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res. 2003, 63:5679-5684.
38. Wrage M., Ruosaari S., Eijk P.P., Kaifi J.T., Hollmen J., Yekebas E.F., Izbicki J.R., Brakenhoff R.H., Streichert T., Riethdorf S., Glatzel M., Ylstra B., Pantel K., Wikman H. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion. Clin. Cancer Res. 2009, 15:1566-1574.
39. Yu M., Bardia A., Aceto N., Bersani F., Madden M.W., Donaldson M.C., Desai R., Zhu H., Comaills V., Zheng Z., Wittner B.S., Stojanov P., Brachtel E., Sgroi D., Kapur R., Shioda T., Ting D.T., Ramaswamy S., Getz G., Iafrate A.J., Benes C., Toner M., Maheswaran S., Haber D.A. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 2014, 345:216-220.
40. Zhang L., Ridgway L.D., Wetzel M.D., Ngo J., Yin W., Kumar D., Goodman J.C., Groves M.D., Marchetti D. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci. Transl Med. 2013, 5. 180ra148.
41. Zhang Z., Shiratsuchi H., Lin J., Chen G., Reddy R.M., Azizi E., Fouladdel S., Chang A.C., Lin L., Jiang H., Waghray M., Luker G., Simeone D.M., Wicha M.S., Beer D.G., Ramnath N., Nagrath S. Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget 2014, 5:12383-12397.